Invention Grant
- Patent Title: Method for catalytic asymmetric synthesis of phosphorus-stereogenic (P-stereogenic) nucleoside derivative and catalyst used therein
-
Application No.: US17967117Application Date: 2022-10-17
-
Publication No.: US11655255B2Publication Date: 2023-05-23
- Inventor: Wanbin Zhang , Mo Wang , Lu Zhang , Xiaohong Huo , Zhenfeng Zhang , Qianjia Yuan , Jianzhong Chen
- Applicant: SPH NO.1 BIOCHEMICAL & PHARMACEUTICAL CO.,LTD. , Shanghai Jiaotong University
- Applicant Address: CN Shanghai
- Assignee: SPH NO.1 BIOCHEMICAL & PHARMACEUTICAL CO., LTD.,Shanghai Jiaotong University
- Current Assignee: SPH NO.1 BIOCHEMICAL & PHARMACEUTICAL CO., LTD.,Shanghai Jiaotong University
- Current Assignee Address: CN Shanghai; CN Shanghai
- Main IPC: C07D487/04
- IPC: C07D487/04

Abstract:
A method for catalytic asymmetric synthesis of a phosphorus-stereogenic (P-stereogenic) nucleoside derivative of formula (3) and a catalyst used therein. The P-stereogenic nucleoside derivative (3) can be hydrolyzed to obtain remdesivir. Specifically, a nucleoside and phosphoryl chloride are subjected to asymmetric reaction under the catalysis of a chiral bicyclic imidazole catalyst in the presence of a base to produce the P-stereogenic nucleoside derivative of formula (3)
Public/Granted literature
Information query